[{"indications": "Indications\u00a0see under Dose", "name": "RABEPRAZOLE SODIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "1 Gastro-intestinal system", "1.3 Antisecretory drugs and mucosal protectants", "1.3.5 Proton pump inhibitors", "RABEPRAZOLE SODIUM"], "cautions": "Cautions\u00a0\n(From 1.3.5 Proton pump inhibitors: British National Formulary)\nCautions\u00a0Proton pump inhibitors may mask the symptoms of gastric cancer; particular care is required in those presenting with \u2018alarm features\u2019 (see Dyspepsia), in such cases gastric malignancy should be ruled out before treatment. A proton pump inhibitor should be prescribed for appropriate indications at the lowest effective dose for the shortest period; the need for long-term treatment should be reviewed periodically.; interactions: Appendix 1 (proton pump inhibitors)", "side-effects": "Side-effects\u00a0\n(From 1.3.5 Proton pump inhibitors: British National Formulary)\nSide-effects\u00a0Side-effects of the proton pump inhibitors include gastro-intestinal disturbances (including nausea, vomiting, abdominal pain, flatulence, diarrhoea, constipation), and headache. Less frequent side-effects include dry mouth, peripheral oedema, dizziness, sleep disturbances, fatigue, paraesthesia, arthralgia, myalgia, rash, and pruritus. Other side-effects reported rarely or very rarely include taste disturbance, stomatitis, hepatitis, jaundice, hypersensitivity reactions (including anaphylaxis, bronchospasm), fever, depression, hallucinations, confusion, gynaecomastia, interstitial nephritis, hyponatraemia, hypomagnesaemia (with long-term treatment), blood disorders (including leucopenia, leucocytosis, pancytopenia, thrombocytopenia), visual disturbances, sweating, photosensitivity, alopecia, Stevens-Johnson syndrome, and toxic epidermal necrolysis. By decreasing gastric acidity, proton pump inhibitors may increase the risk of gastro-intestinal infections (including Clostridium difficile infection).Rebound acid hypersecretion and protracted dyspepsia may occur after stopping prolonged treatment with a proton pump inhibitor.; also cough, influenza-like syndrome,\r\nand rhinitis; less commonly chest pain and nervousness; rarely anorexia and weight gain", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/73249.htm", "doses": ["Benign gastric ulcer, 20\u00a0mg daily in the morning for 8\r\nweeks", "Duodenal ulcer, 20\u00a0mg daily in the morning for 4 weeks", "Duodenal and benign gastric ulcer associated with Helicobacter pylori, see Recommended Regimens for Helicobacter pylori Eradication", "Gastro-oesophageal reflux disease, 20\u00a0mg once daily for 4\u20138\r\nweeks; maintenance 10\u201320\u00a0mg daily; symptomatic treatment in the absence\r\nof oesophagitis, 10\u00a0mg daily for up to 4 weeks, then 10\u00a0mg daily when\r\nrequired", "Zollinger\u2013Ellison syndrome, initially 60\u00a0mg once daily adjusted\r\naccording to response (max. 120\u00a0mg daily); doses above 100\u00a0mg daily\r\ngiven in 2 divided doses", "child not recommended"], "pregnancy": "Pregnancy\u00a0manufacturer advises avoid\u2014no information available"}]